Amedisys Inc's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2025 to a ratio of 7.93, this is below the company average, and notable indication of worsening business environment. Average receivable collection period, for the Amedisys Inc in Jun 30 2025 quarter, has decreased to 46 days, compared to 49 days, in the Mar 31 2025 quarter.

If we take a look into Healthcare sector 160 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2025 from 788 to 1486.

What is Receivable Turnover Ratio?
What is Amedisys Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

AMED Receivables Turnover Ratio	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter
Y / Y Receivable Change	-17.2 %	-11.05 %	-5.52 %	-5.8 %	28.02 %
Y / Y Revenue Change	5.19 %	4.09 %	4.78 %	5.65 %	6.91 %
Receivable Turnover Ratio (TTM)	7.93	7.45	7.15	6.98	6.79
AMED's Total Ranking	# 1486	# 788	# 1608	# 1672	# 665
Accounts Receivable average collection period days	46	49	51	52	54
Seq. Receivable Change	-7.55 %	7.96 %	-1.65 %	-15.65 %	-0.68 %
Seq. Revenue Change	4.55 %	-0.55 %	1.77 %	-0.59 %	3.46 %

Receivable Turnover Company Ranking
Within:	No.
Healthcare Facilities Industry	# 22
Healthcare Sector	# 161
Overall Market	# 1486

Receivable Turnover Ratio Statistics
High	Average	Low
11.5	8.68	6.79
(June 30. 2015)		(Jun 30 2024)

AMED Company Profile • Back to AMED Efficiency Comparisons • Compare AMED Receivables Turnover Ratio to its Competitors

Financial Statements
Amedisys Inc's Accounts Receivable	$ 296 Millions	Visit AMED's Balance sheet
Amedisys Inc's Sales TTM	$ 2,402 Millions	Visit AMED's Income Statement
Sources of AMED's Revenues		Visit AMED's Sales by Geography

Other Accounts Receivable Turnover Ratios
Healthcare Facilities Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
AMED's Receivable Turnover Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
AMED's Growth Rates	AMED's Roa	AMED's Inventory Turnover Ratio	AMED's Dividend Comparisons
AMED's Profitability Ratios	AMED's Roi	AMED's Asset Turnover Ratio	AMED's Dividend Growth
AMED's Valuation Ratios	AMED's Roe	AMED's Financial Strength Ratios	AMED's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2025, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2025	Receivable at quarter ending Jun 30 2025
Spero Therapeutics Inc	21.81	$ 48.576 Millions	$ 2.227 Millions
Meiragtx Holdings Plc	21.55	$ 37.917 Millions	$ 1.760 Millions
Plus Therapeutics Inc	20.83	$ 5.317 Millions	$ 0.255 Millions
Newamsterdam Pharma Company N v	20.54	$ 64.006 Millions	$ 3.116 Millions
Bespoke Extracts Inc	20.45	$ 1.233 Millions	$ 0.060 Millions
Marpai Inc	20.19	$ 23.673 Millions	$ 1.172 Millions
Precipio inc	19.83	$ 21.242 Millions	$ 1.071 Millions
Sonida Senior Living Inc	19.77	$ 352.129 Millions	$ 17.815 Millions
Neuraxis Inc	19.23	$ 3.218 Millions	$ 0.167 Millions
Nurix Therapeutics Inc	18.61	$ 88.381 Millions	$ 4.750 Millions
Macrogenics Inc	18.32	$ 165.494 Millions	$ 9.034 Millions
Innovage Holding Corp	17.92	$ 853.699 Millions	$ 47.637 Millions
Clene Inc	17.88	$ 0.286 Millions	$ 0.016 Millions
Valion Bio Inc	17.77	$ 0.462 Millions	$ 0.026 Millions
Xoma Royalty Corporation	17.55	$ 44.952 Millions	$ 2.561 Millions
Vivos Therapeutics Inc	17.37	$ 14.050 Millions	$ 0.809 Millions
Talkspace Inc	16.84	$ 201.745 Millions	$ 11.979 Millions
Generation Bio Co	16.70	$ 21.230 Millions	$ 1.271 Millions
Scorpius Holdings inc	16.57	$ 2.409 Millions	$ 0.145 Millions
Petvivo Holdings Inc	16.51	$ 0.986 Millions	$ 0.060 Millions
Milestone Scientific Inc	15.95	$ 8.888 Millions	$ 0.557 Millions
Longeveron Inc	15.82	$ 2.073 Millions	$ 0.131 Millions
Siga Technologies Inc	15.31	$ 179.639 Millions	$ 11.732 Millions
Kiniksa Pharmaceuticals International Plc	15.28	$ 529.332 Millions	$ 34.647 Millions
Safe Pro Group Inc	14.98	$ 1.496 Millions	$ 0.100 Millions
Quipt Home Medical Corp	14.94	$ 422.961 Millions	$ 28.311 Millions
Ethema Health Corporation	14.53	$ 11.650 Millions	$ 0.802 Millions
Amneal Pharmaceuticals Inc	14.50	$ 2,851.220 Millions	$ 196.597 Millions
Inmed Pharmaceuticals Inc	14.32	$ 4.943 Millions	$ 0.345 Millions
Mannkind Corporation	14.03	$ 301.736 Millions	$ 21.508 Millions

Date modified: 2026-06-22T14:32:45+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.